预测原发性骨髓纤维化长期生存
该研究分析217例2001年前诊断的原发性骨髓纤维化患者,识别与长期生存相关的诊断时协变量。多变量分析中年龄<50岁、血小板>450×10⁹/L和0级骨髓纤维化独立预测长期生存,并经Cox回归验证。
要点
- 年龄<50岁、血小板>450×10⁹/L和0级骨髓纤维化独立预测长期生存。
- 长期生存者较少贫血、脾大、CD34阳性细胞增高和JAK2V617F突变。
- 诊断时识别长期生存者可提供预后信息并影响治疗决策。
核心结论
- 年龄<50岁、血小板>450×10⁹/L和0级骨髓纤维化独立预测原发性骨髓纤维化长期生存。
研究设计与样本
- 回顾性分析217例2001年前诊断的原发性骨髓纤维化患者数据。
主要发现
- 长期生存者更多为女性、年龄<50岁,较少贫血、脾大、血CD34阳性细胞增高和JAK2V617F突变,更多0级骨髓纤维化和血小板增高。
- 多变量logistic回归中年龄<50岁、血小板>450×10⁹/L和0级骨髓纤维化独立预测长期生存,Cox回归landmark分析证实。
- 长期生存者随访期间贫血和血小板减少累积发生率较低。
临床怎么用
- 诊断时评估年龄、血小板计数和骨髓纤维化分级有助于识别可能长期生存的患者。
- 识别长期生存者可提供预后信息并影响治疗决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We interrogated data from 217 subjects with primary myelofibrosis (PMF) diagnosed before 2001 to identify covariates at diagnosis associated with long-term survival. Forty-one survived more than 25 years. Long-term survivors were more often female, younger than 50 years and less likely to have anemia, splenomegaly, increased blood CD34-positive cells, a JAK2V617F variant, and more likely to have grade-0 bone marrow fibrosis and increased platelets. In multivariable logistic regression analyses, age <50 years, platelet count >450 × 10⁹/L, and grade-0 bone marrow fibrosis independently predicted long-term survival. These co-variate associations were confirmed in Cox regression with landmark analyses. Long-term survivors had a lower cumulative incidence of anemia and thrombocytopenia during follow-up. Identifying long-term survivors at diagnosis provides clinically meaningful prognostic information in PMF and may influence therapy decisions.
引用
- Barosi G, Rosti V, De Silvestri A, et al. Predicting long-term survival in primary myelofibrosis. Leukemia. 2026. PMID: 42897234. doi:10.1038/s41375-026-03177-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。